FDA Adverse Event
Injury
Summary report: N
OVITEX REINFORCED TISSUE MATRIX
MDR report key: 18798391
·
Received February 28, 2024
Report
- Report Number
- 3010513348-2024-00005
- Event Type
- Injury
- Date Received
- February 28, 2024
- Date of Event
- February 13, 2024
- Report Date
- February 28, 2024
- Manufacturer
- AROA BIOSURGERY
- Product Code
- FTM
- Adverse Event
- Yes
- Report Source
- Distributor report
- Reporter Location
- TX, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
Additional Manufacturer Narrative · 0
PLEASE NOTE THAT DATE OF IMPLANT IS APPROXIMATE TO THE MONTH OF IMPLANT REPORTED BY THE PHYSICIAN. IT CANNOT BE DETERMINED WHETHER THE DEVICE CAUSED OR CONTRIBUTED TO THE EVENT NOTED. SEROMA, INFECTION, AND REOPERATION ARE KNOWN ADVERSE EVENTS AND POTENTIAL OUTCOMES ASSOCIATED WITH HERNIA REPAIR SURGERY.
Description of Event or Problem · 0
IT WAS REPORTED THAT A PATIENT WHO UNDERWENT IPOM REPAIR WITH OVITEX 2S IN APPROXIMATELY (B)(6) 2023 RETURNED IN (B)(6) 2023 WITH A SEROMA. THIS WAS DRAINED UNDER IR A DRAIN PLACED IN (B)(6) 2023 WITH THE DRAIN REMOVED 3 WEEKS LATER. ON (B)(6) 2024 IT WAS REPORTED THAT THE SEROMA CONTINUED AND APPEARED TO HAVE BECOME INFECTED AND THE DEVICE WAS TO BE EXPLANTED THAT DAY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 497855 | OVITEX REINFORCED TISSUE MATRIX | SURGICAL MESH | FTM | AROA BIOSURGERY |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 49 YR | Female | Hospitalization| R |